Parenteral Nutrition Market Revenue, Opportunity, Segment and Key Trends 2017-2023
Added: (Wed Feb 07 2018)
A new research report published by Infinium Global Research identified that the Global Parenteral Nutrition Market is set to grow due to growing prevalence of chronic diseases such as bowel cancer, and colorectal cancer among others; and increasing incidences of malnutrition in the near future.
Government initiatives in emerging markets and economic development in emerging markets of Asia, Latin America and Africa to augment the healthcare expenditure per capita, and novel combinations of parenteral nutrition are expected to bring new opportunities. The global market size of parenteral nutrition was USD 4.86 billion in 2016 and it is projected to reach to 7.62 billion growing at a CAGR of 6.7% between 2017 and 2023.
To Get Sample Pages of this Report: https://www.infiniumglobalresearch.com/Reports/MakeSampleRequest/827
North America accounted for the largest market for parenteral nutrition over the past couple years with market share over 41%. The Europe accounted for the second largest market share after North America. Presence of medical reimbursement facilities and technological advancements in the region are considered to be the key factors driving the dominance of North America in global parenteral nutrition market. The Asia-Pacific region is anticipated to grow at a CAGR of. The growth of Asia pacific parenteral nutrition market is considered to be driven by rapidly increasing per capita healthcare expenditure and higher focus on research in parenteral nutrition by key players across the region. Developing economies in Asia pacific such as India and China are likely to bring more opportunities for major player over the forecast period.
Increasing cases of malnutrition are likely to provide opportunities for the key players in the world.
Malnutrition is one of the major issues in the major countries in the world. Several underdeveloped, and developing countries have a significant number of children suffering from malnutrition. Children under the age of 5 are more vulnerable and face stunting and nutrition deficiency in majority of these countries. The governments of several countries now have taken initiative to eradicate malnutrition among the children. Since 1990 the global prevalence of stunting has decreased with an average annual rate of reduction of 2.1% per year during this period. The number of stunted children under-five years of age in the world has declined from an estimated 253 million (241, 265 million) in 1990 to 165 million (151, 179 million).
Browse the Detailed TOC of the Report on Parenteral Nutrition Market
The report segments the global parenteral nutrition market as:
Market Segment based on Type
Market Segment based on Dosage form
SichuanKelun Pharmaceutical Co., Ltd.
Grifols International S.A.
Claris LifeSciences Ltd.
Braun Melsungen AG
Baxter International, Inc.
Other companiesSubmitted by:Infinium Global Research